Fairhaven Pharmaceuticals Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.79M
Fairhaven Pharmaceuticals General Information
Description
Fairhaven Pharmaceuticals was a developer of oral therapeutics intended to treat severe inflammatory conditions. The company used to offer a preclinical research program of small molecule antagonists and other related services to develop oral therapeutics, enabling clinicians to treat patients with inflammatory conditions.
Contact Information
Corporate Office
- 1917 West 4th Avenue
- Suite 390
- Vancouver, British Columbia
- Canada
Corporate Office
- 1917 West 4th Avenue
- Suite 390
- Vancouver, British Columbia
- Canada
Fairhaven Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 16-Jul-2020 | $2.79M | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Generating Revenue |
Fairhaven Pharmaceuticals Patents
Fairhaven Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022417301-A1 | Oxer1 antagonists and uses thereof | Pending | 20-Dec-2021 | ||
| CA-3240538-A1 | Oxer1 antagonists and uses thereof | Pending | 20-Dec-2021 | ||
| EP-4452940-A1 | Oxer1 antagonists and uses thereof | Pending | 20-Dec-2021 | ||
| EP-4452940-A4 | Oxer1 antagonists and uses thereof | Pending | 20-Dec-2021 | ||
| JP-2025503491-A | Oxer1 antagonists and uses thereof | Pending | 20-Dec-2021 | C07D471/04 |
Fairhaven Pharmaceuticals Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AmorChem | Venture Capital | Minority | ||
| Genesys Capital | Venture Capital | Minority |
Fairhaven Pharmaceuticals FAQs
-
Where is Fairhaven Pharmaceuticals headquartered?
Fairhaven Pharmaceuticals is headquartered in Vancouver, Canada.
-
What industry is Fairhaven Pharmaceuticals in?
Fairhaven Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Fairhaven Pharmaceuticals a private or public company?
Fairhaven Pharmaceuticals is a Private company.
-
What is the current valuation of Fairhaven Pharmaceuticals?
The current valuation of Fairhaven Pharmaceuticals is .
-
What is Fairhaven Pharmaceuticals’s current revenue?
The current revenue for Fairhaven Pharmaceuticals is .
-
Who are Fairhaven Pharmaceuticals’s investors?
AmorChem and Genesys Capital have invested in Fairhaven Pharmaceuticals.
-
When was Fairhaven Pharmaceuticals acquired?
Fairhaven Pharmaceuticals was acquired on 16-Jul-2020.
-
Who acquired Fairhaven Pharmaceuticals?
Fairhaven Pharmaceuticals was acquired by Liminal Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process